A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol ...

Although the first GLP-1 drug was approved by the US Food and Drug Administration (FDA) in the early 2000s, it wasn't until a ...

Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

A new review reports that nine people taking semaglutide and tirzepatide — the active ingredient in GLP-1 medications — ...

Glucagon-like peptide-1 (GLP-1) is a well-known medication used by physicians to treat Type 2 diabetes. GLP-1 has also become ...

CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

Unfortunately, we also found that GLP-1 drugs come with significant side effects and increase the risk of 19 health conditions we studied, such as gastrointestinal issues, kidney stones ...

The spot “is a clear violation” of the FDCA, “which requires that advertising for prescription drugs — including compounded ...

GLP-1 medications initially were used to help people with diabetes improve their insulin resistance and hunger cravings.

can be an uncomfortable side effect of GLP-1 medications, as these drugs slow the digestive process, causing food to stay in the stomach longer. “It’s helpful to limit or avoid common triggers ...

Alexandra Sowa's new book The Ozempic Revolution is intended to be the "first comprehensive user guide" to GLP-1 drugs like Ozempic.